University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Utilizing Helpline for Opioid Dependence Treatment
- Conditions
- Interventions
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 1000
- Registration Number
- NCT03969238
- Locations
- 🇺🇸
UVA Center for Leading Edge Addiction Research, Charlottesville, Virginia, United States
Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 37
- Registration Number
- NCT03968211
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-05-24
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 36
- Registration Number
- NCT03962465
- Locations
- 🇺🇸
University of Wisconsin, Madison, Wisconsin, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
🇺🇸Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
Early Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-04-08
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 88
- Registration Number
- NCT03905941
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 144
- Registration Number
- NCT03905603
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Trial to Investigate the in Silico Optimization of Insulin Treatments
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-03-29
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 35
- Registration Number
- NCT03895138
- Locations
- 🇺🇸
University of Vrginia, Charlottesville, Virginia, United States
Impact of Acute Exercise on Vascular Insulin Sensitivity in Metabolic Syndrome
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-03-28
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 16
- Registration Number
- NCT03894527
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Functional Roles of Dorsolateral Prefrontal Cortex
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-03-20
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 90
- Registration Number
- NCT03882931
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
- First Posted Date
- 2019-03-20
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 60
- Registration Number
- NCT03883412
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia
- Conditions
- Interventions
- First Posted Date
- 2019-03-15
- Last Posted Date
- 2019-04-17
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 300
- Registration Number
- NCT03876470
© Copyright 2024. All Rights Reserved by MedPath